Bempedoic acid Articles

Articles
Effect of bempedoic acid on mortality and cardiovascular events in primary and secondary prevention: A post-hoc analysis of the CLEAR-outcomes trial
Sayed A, Brophy JM
Journal:
Int J Cardiol

First published: April 19, 2024 DOI: 10.1016/j.ijcard.2024.132074
View
- Share
Articles
Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex
Cho L, Plutzky J, Brennan D, et al.
Journal:
Circulation

First published: April 6, 2024 DOI: 10.1161/CIRCULATIONAHA.123.067691
View
- Share
Articles
Unique features of dyslipidemia in women across a lifetime and a tailored approach to management
Patel N, Mittal N, Wilkinson MJ, et al.
Journal:
Am J Prev Cardiol

First published: April 5, 2024 DOI: 10.1016/j.ajpc.2024.100666
View
- Share
Articles
Assessing the Role of Bempedoic Acid in Lipid-Lowering Therapy
Fernandez-Vazquez D, Weideman S, Banerjee S
Journal:
Am J Cardiol

First published: February 16, 2024 DOI: 10.1016/j.amjcard.2024.02.002
View
- Share
Articles
Bempedoic acid: new evidence and recommendations on use
Paponja K, Pećin I, Reiner Ž, et al.
Journal:
Curr Opin Lipidol

First published: February 1, 2024 DOI: 10.1097/MOL.0000000000000911
View
- Share
Articles
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial
Nicholls SJ, Nelson AJ, Lincoff AM, et al.
Journal:
JAMA Cardiol

First published: January 17, 2024 DOI: 10.1001/jamacardio.2023.5155
View
- Share
Articles
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
Duell PB, Banach M, Catapano AL, et al.
Journal:
J Clin Lipidol

First published: January 11, 2024 DOI: 10.1016/j.jacl.2023.12.005
View
- Share
Articles
The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias
Tokgözoğlu L, Orringer C, Catapano AL
Journal:
Eur Heart J

First published: December 28, 2023 DOI: 10.1093/eurheartj/ehad837
View
- Share
Articles
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
Ray KK, Nicholls SJ, Li N, et al.
Journal:
Lancet Diabetes Endocrinol

First published: December 4, 2023 DOI: 10.1016/S2213-8587(23)00316-9
View
- Share
Articles
Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use
Drexel H, Mader A
Journal:
Cardiology

First published: November 21, 2023 DOI: 10.1159/000535372
View
- Share
Articles
Bempedoic Acid for Primary Prevention of Cardiovascular Events-Reply
Nissen SE, Nicholls SJ, Lincoff AM
Journal:
JAMA

First published: November 7, 2023 DOI: 10.1001/jama.2023.17341
View
- Share
Articles
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance
Bays HE, Bloedon LT, Lin G, et al.
Journal:
J Clin Lipidol

First published: October 31, 2023 DOI: 10.1016/j.jacl.2023.10.011
View
- Share

1 2

Bempedoic acid Articles

Articles

Effect of bempedoic acid on mortality and cardiovascular events in primary and secondary prevention: A post-hoc analysis of the CLEAR-outcomes trial

Sayed A, Brophy JM

Articles

Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex

Cho L, Plutzky J, Brennan D, et al.

Articles

Unique features of dyslipidemia in women across a lifetime and a tailored approach to management

Patel N, Mittal N, Wilkinson MJ, et al.

Articles

Assessing the Role of Bempedoic Acid in Lipid-Lowering Therapy

Fernandez-Vazquez D, Weideman S, Banerjee S

Articles

Bempedoic acid: new evidence and recommendations on use

Paponja K, Pećin I, Reiner Ž, et al.

Articles

Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial

Nicholls SJ, Nelson AJ, Lincoff AM, et al.

Articles

Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials

Duell PB, Banach M, Catapano AL, et al.

Articles

The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias

Tokgözoğlu L, Orringer C, Catapano AL

Articles

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

Ray KK, Nicholls SJ, Li N, et al.

Articles

Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use

Drexel H, Mader A

Articles

Bempedoic Acid for Primary Prevention of Cardiovascular Events-Reply

Nissen SE, Nicholls SJ, Lincoff AM

Articles

Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance

Bays HE, Bloedon LT, Lin G, et al.

Articles

Effect of bempedoic acid on mortality and cardiovascular events in primary and secondary prevention: A post-hoc analysis of the CLEAR-outcomes trial

Sayed A, Brophy JM

Share

Articles

Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex

Cho L, Plutzky J, Brennan D, et al.

Share

Articles

Unique features of dyslipidemia in women across a lifetime and a tailored approach to management

Patel N, Mittal N, Wilkinson MJ, et al.

Share

Articles

Assessing the Role of Bempedoic Acid in Lipid-Lowering Therapy

Fernandez-Vazquez D, Weideman S, Banerjee S

Share

Articles

Bempedoic acid: new evidence and recommendations on use

Paponja K, Pećin I, Reiner Ž, et al.

Share

Articles

Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial

Nicholls SJ, Nelson AJ, Lincoff AM, et al.

Share

Articles

Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials

Duell PB, Banach M, Catapano AL, et al.

Share

Articles

The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias

Tokgözoğlu L, Orringer C, Catapano AL

Share

Articles

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

Ray KK, Nicholls SJ, Li N, et al.

Share

Articles

Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use

Drexel H, Mader A

Share

Articles

Bempedoic Acid for Primary Prevention of Cardiovascular Events-Reply

Nissen SE, Nicholls SJ, Lincoff AM

Share

Articles

Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance

Bays HE, Bloedon LT, Lin G, et al.

Share